Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, GABA-A | 68 | 1997 | 627 | 3.410 |
Why?
|
| Lorazepam | 22 | 1997 | 145 | 1.380 |
Why?
|
| MSH Release-Inhibiting Hormone | 8 | 1990 | 9 | 0.560 |
Why?
|
| Chlorides | 22 | 1995 | 667 | 0.550 |
Why?
|
| Anti-Anxiety Agents | 11 | 1994 | 390 | 0.550 |
Why?
|
| Flumazenil | 20 | 1994 | 84 | 0.500 |
Why?
|
| gamma-Aminobutyric Acid | 11 | 1995 | 1121 | 0.500 |
Why?
|
| Benzodiazepines | 15 | 1994 | 1101 | 0.490 |
Why?
|
| Clonazepam | 14 | 1994 | 136 | 0.470 |
Why?
|
| Substance Withdrawal Syndrome | 9 | 1997 | 632 | 0.410 |
Why?
|
| Cerebral Cortex | 29 | 1997 | 5708 | 0.360 |
Why?
|
| Alprazolam | 10 | 1994 | 98 | 0.340 |
Why?
|
| Drug Tolerance | 11 | 1997 | 376 | 0.330 |
Why?
|
| Muscimol | 13 | 1995 | 69 | 0.320 |
Why?
|
| Cocaine | 4 | 1994 | 1007 | 0.300 |
Why?
|
| Benzodiazepinones | 7 | 1993 | 51 | 0.290 |
Why?
|
| Chick Embryo | 12 | 1995 | 982 | 0.270 |
Why?
|
| Motor Activity | 17 | 1997 | 2714 | 0.250 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 1995 | 2408 | 0.230 |
Why?
|
| Membrane Transport Proteins | 3 | 1994 | 1028 | 0.230 |
Why?
|
| Corpus Striatum | 3 | 1994 | 1221 | 0.220 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 1997 | 895 | 0.220 |
Why?
|
| Brain | 20 | 1994 | 26385 | 0.220 |
Why?
|
| Spermine | 4 | 1995 | 70 | 0.210 |
Why?
|
| Behavior, Animal | 5 | 1994 | 1881 | 0.200 |
Why?
|
| Carbolines | 3 | 1991 | 265 | 0.190 |
Why?
|
| Pentylenetetrazole | 4 | 1997 | 69 | 0.190 |
Why?
|
| Appetite Depressants | 2 | 1991 | 110 | 0.180 |
Why?
|
| Animals | 82 | 1997 | 168757 | 0.170 |
Why?
|
| Mice | 61 | 1997 | 81183 | 0.170 |
Why?
|
| Mice, Inbred Strains | 10 | 1994 | 1827 | 0.170 |
Why?
|
| Brain Chemistry | 11 | 1995 | 981 | 0.170 |
Why?
|
| Interleukin-1 | 2 | 1994 | 1263 | 0.170 |
Why?
|
| Dizocilpine Maleate | 3 | 1995 | 176 | 0.170 |
Why?
|
| Insurance Claim Review | 2 | 1994 | 720 | 0.170 |
Why?
|
| Convulsants | 5 | 1993 | 70 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 3 | 1992 | 1162 | 0.160 |
Why?
|
| Membrane Glycoproteins | 3 | 1994 | 3768 | 0.160 |
Why?
|
| Piperazines | 3 | 1997 | 2488 | 0.160 |
Why?
|
| RNA, Messenger | 6 | 1993 | 13033 | 0.160 |
Why?
|
| Choline | 2 | 1990 | 493 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 4 | 1994 | 4462 | 0.150 |
Why?
|
| Spermidine | 2 | 1994 | 56 | 0.150 |
Why?
|
| Calcium | 5 | 1995 | 5756 | 0.150 |
Why?
|
| Carrier Proteins | 3 | 1994 | 5021 | 0.140 |
Why?
|
| N-Methylaspartate | 5 | 1995 | 231 | 0.130 |
Why?
|
| Pregnenolone | 1 | 1995 | 26 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1997 | 449 | 0.130 |
Why?
|
| Biogenic Polyamines | 1 | 1994 | 4 | 0.120 |
Why?
|
| Quisqualic Acid | 2 | 1990 | 36 | 0.120 |
Why?
|
| Expert Systems | 1 | 1994 | 81 | 0.120 |
Why?
|
| Ion Channels | 8 | 1993 | 1056 | 0.120 |
Why?
|
| Kinetics | 12 | 1991 | 6473 | 0.120 |
Why?
|
| Isoquinolines | 2 | 1993 | 367 | 0.120 |
Why?
|
| Kainic Acid | 2 | 1990 | 199 | 0.110 |
Why?
|
| Glutamic Acid | 3 | 1994 | 1169 | 0.110 |
Why?
|
| Peripheral Nervous System | 1 | 1994 | 150 | 0.110 |
Why?
|
| Management Information Systems | 1 | 1993 | 50 | 0.110 |
Why?
|
| Electroshock | 1 | 1993 | 122 | 0.110 |
Why?
|
| Neurons | 6 | 1994 | 9338 | 0.110 |
Why?
|
| Utilization Review | 1 | 1994 | 392 | 0.110 |
Why?
|
| Glutamates | 2 | 1990 | 398 | 0.110 |
Why?
|
| Quinolinium Compounds | 1 | 1991 | 15 | 0.100 |
Why?
|
| Receptors, GABA | 1 | 1994 | 288 | 0.100 |
Why?
|
| Down-Regulation | 6 | 1993 | 3002 | 0.100 |
Why?
|
| Dioxolanes | 1 | 1991 | 25 | 0.100 |
Why?
|
| Platelet Activating Factor | 1 | 1991 | 149 | 0.100 |
Why?
|
| Binding Sites | 9 | 1991 | 6114 | 0.100 |
Why?
|
| Diterpenes | 1 | 1991 | 173 | 0.100 |
Why?
|
| Seizures | 6 | 1997 | 2859 | 0.090 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1990 | 178 | 0.090 |
Why?
|
| Nervous System | 1 | 1993 | 554 | 0.090 |
Why?
|
| Flunitrazepam | 5 | 1990 | 20 | 0.090 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 3 | 1995 | 58 | 0.090 |
Why?
|
| Psychotropic Drugs | 1 | 1995 | 894 | 0.090 |
Why?
|
| Triazolam | 2 | 1988 | 16 | 0.080 |
Why?
|
| Quinolines | 2 | 1991 | 732 | 0.080 |
Why?
|
| Adrenalectomy | 2 | 1988 | 341 | 0.080 |
Why?
|
| Lactones | 1 | 1991 | 329 | 0.080 |
Why?
|
| 20-alpha-Dihydroprogesterone | 1 | 1988 | 2 | 0.080 |
Why?
|
| Desoxycorticosterone | 1 | 1988 | 50 | 0.080 |
Why?
|
| Flurazepam | 1 | 1988 | 8 | 0.080 |
Why?
|
| Acetylcholine | 1 | 1990 | 621 | 0.080 |
Why?
|
| Managed Care Programs | 1 | 1994 | 950 | 0.080 |
Why?
|
| Estazolam | 1 | 1987 | 1 | 0.080 |
Why?
|
| Chloride Channels | 4 | 1990 | 227 | 0.080 |
Why?
|
| Cerebellum | 6 | 1993 | 1488 | 0.080 |
Why?
|
| GABA-A Receptor Antagonists | 3 | 1993 | 62 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 1 | 1988 | 438 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 1994 | 1572 | 0.080 |
Why?
|
| Barbiturates | 1 | 1988 | 114 | 0.080 |
Why?
|
| Corticosterone | 1 | 1988 | 310 | 0.070 |
Why?
|
| Hippocampus | 9 | 1997 | 3675 | 0.070 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 3 | 1994 | 422 | 0.070 |
Why?
|
| Male | 63 | 2007 | 350118 | 0.070 |
Why?
|
| Cells, Cultured | 8 | 1995 | 19229 | 0.070 |
Why?
|
| Imidazoles | 1 | 1992 | 1206 | 0.070 |
Why?
|
| Atenolol | 1 | 1986 | 100 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 1993 | 6171 | 0.070 |
Why?
|
| Pheochromocytoma | 1 | 1988 | 337 | 0.070 |
Why?
|
| Albuterol | 1 | 1986 | 208 | 0.070 |
Why?
|
| Blotting, Northern | 3 | 1992 | 1581 | 0.070 |
Why?
|
| Pyridazines | 3 | 1992 | 202 | 0.060 |
Why?
|
| Nerve Growth Factors | 1 | 1988 | 574 | 0.060 |
Why?
|
| Substance-Related Disorders | 3 | 1991 | 4258 | 0.060 |
Why?
|
| Up-Regulation | 2 | 1991 | 4217 | 0.060 |
Why?
|
| Marketing | 1 | 2007 | 212 | 0.060 |
Why?
|
| Fura-2 | 2 | 1995 | 109 | 0.060 |
Why?
|
| Stress, Psychological | 2 | 1991 | 4245 | 0.060 |
Why?
|
| Progesterone | 1 | 1988 | 776 | 0.060 |
Why?
|
| Aldosterone | 1 | 1988 | 877 | 0.060 |
Why?
|
| Depressive Disorder | 2 | 1993 | 3748 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1988 | 740 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 1994 | 5867 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 9 | 1994 | 10943 | 0.050 |
Why?
|
| Glycine | 2 | 1995 | 671 | 0.050 |
Why?
|
| Ethanol | 1 | 1988 | 1342 | 0.050 |
Why?
|
| Binding, Competitive | 3 | 1994 | 1157 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 1990 | 2866 | 0.050 |
Why?
|
| Asbestos | 1 | 1983 | 251 | 0.050 |
Why?
|
| Drug Industry | 1 | 2007 | 746 | 0.050 |
Why?
|
| Pyridines | 1 | 1992 | 2825 | 0.050 |
Why?
|
| Dexamethasone | 1 | 1988 | 1951 | 0.050 |
Why?
|
| Interprofessional Relations | 1 | 2007 | 1011 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 1993 | 2838 | 0.050 |
Why?
|
| Mast Cells | 1 | 1988 | 1544 | 0.050 |
Why?
|
| Time Factors | 11 | 1994 | 40075 | 0.050 |
Why?
|
| DNA | 1 | 1994 | 7301 | 0.040 |
Why?
|
| Azabicyclo Compounds | 2 | 1992 | 68 | 0.040 |
Why?
|
| Blood Platelets | 1 | 1990 | 2508 | 0.040 |
Why?
|
| Aging | 4 | 1991 | 8664 | 0.040 |
Why?
|
| Sulfur Radioisotopes | 4 | 1991 | 116 | 0.040 |
Why?
|
| Reference Values | 3 | 1992 | 4982 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 1990 | 2690 | 0.040 |
Why?
|
| Fluoxetine | 2 | 1993 | 749 | 0.040 |
Why?
|
| Pregnancy | 7 | 1995 | 29144 | 0.040 |
Why?
|
| T-Lymphocytes | 4 | 1983 | 10180 | 0.040 |
Why?
|
| Chlorine | 2 | 1995 | 50 | 0.040 |
Why?
|
| Base Sequence | 4 | 1994 | 12797 | 0.040 |
Why?
|
| Gene Expression | 1 | 1990 | 7799 | 0.040 |
Why?
|
| Chickens | 2 | 1989 | 865 | 0.040 |
Why?
|
| Drug Interactions | 3 | 1997 | 1460 | 0.040 |
Why?
|
| Ligands | 3 | 1992 | 3282 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1988 | 2186 | 0.040 |
Why?
|
| Radioisotopes | 2 | 1995 | 499 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 1994 | 18111 | 0.030 |
Why?
|
| Protein Binding | 3 | 1994 | 9386 | 0.030 |
Why?
|
| Nimodipine | 1 | 1995 | 55 | 0.030 |
Why?
|
| Drug Administration Schedule | 4 | 1992 | 4933 | 0.030 |
Why?
|
| Neoplasms | 2 | 1995 | 21683 | 0.030 |
Why?
|
| RNA Probes | 2 | 1991 | 113 | 0.030 |
Why?
|
| Putrescine | 1 | 1994 | 40 | 0.030 |
Why?
|
| Synaptosomes | 2 | 1991 | 115 | 0.030 |
Why?
|
| Biotransformation | 3 | 1988 | 168 | 0.030 |
Why?
|
| Insurance, Physician Services | 1 | 1993 | 24 | 0.030 |
Why?
|
| Pimozide | 1 | 1993 | 21 | 0.030 |
Why?
|
| Polyamines | 1 | 1994 | 120 | 0.030 |
Why?
|
| Cocarcinogenesis | 1 | 1993 | 54 | 0.030 |
Why?
|
| Rats | 4 | 1993 | 24260 | 0.030 |
Why?
|
| Chlordiazepoxide | 2 | 1989 | 42 | 0.030 |
Why?
|
| Arrhythmia, Sinus | 1 | 1993 | 56 | 0.030 |
Why?
|
| Species Specificity | 2 | 1988 | 2478 | 0.030 |
Why?
|
| Ion Transport | 1 | 1994 | 320 | 0.030 |
Why?
|
| Amitriptyline | 1 | 1993 | 110 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 1994 | 313 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 1988 | 3129 | 0.030 |
Why?
|
| Membrane Proteins | 4 | 1990 | 7880 | 0.030 |
Why?
|
| Ginkgolides | 1 | 1991 | 4 | 0.030 |
Why?
|
| Luciferases | 1 | 1994 | 733 | 0.030 |
Why?
|
| RNA | 2 | 1993 | 2749 | 0.030 |
Why?
|
| Smoking | 3 | 1983 | 8987 | 0.020 |
Why?
|
| Anticonvulsants | 2 | 1993 | 1916 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 1994 | 4420 | 0.020 |
Why?
|
| Receptors, Amino Acid | 1 | 1990 | 30 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 2 | 1990 | 425 | 0.020 |
Why?
|
| Bradycardia | 1 | 1993 | 307 | 0.020 |
Why?
|
| Carbamazepine | 1 | 1991 | 229 | 0.020 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1990 | 62 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 427 | 0.020 |
Why?
|
| Cost Control | 1 | 1993 | 624 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 1994 | 2050 | 0.020 |
Why?
|
| Ouabain | 1 | 1990 | 264 | 0.020 |
Why?
|
| Naloxone | 2 | 1989 | 367 | 0.020 |
Why?
|
| Sesterterpenes | 1 | 1989 | 7 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1994 | 794 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 4 | 1983 | 9274 | 0.020 |
Why?
|
| Picrotoxin | 1 | 1989 | 65 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1990 | 554 | 0.020 |
Why?
|
| Ataxia | 2 | 1990 | 304 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1990 | 238 | 0.020 |
Why?
|
| Humans | 27 | 2007 | 744343 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 1375 | 0.020 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 1989 | 108 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 1989 | 374 | 0.020 |
Why?
|
| Hypothalamus | 3 | 1991 | 1063 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1991 | 1420 | 0.020 |
Why?
|
| Half-Life | 2 | 1987 | 661 | 0.020 |
Why?
|
| Methionine | 1 | 1991 | 590 | 0.020 |
Why?
|
| Methacholine Compounds | 1 | 1988 | 35 | 0.020 |
Why?
|
| Physicians | 1 | 2007 | 4567 | 0.020 |
Why?
|
| Adrenal Medulla | 1 | 1988 | 58 | 0.020 |
Why?
|
| Aminooxyacetic Acid | 1 | 1988 | 7 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1991 | 456 | 0.020 |
Why?
|
| Quinoxalines | 1 | 1990 | 290 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 1989 | 243 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1993 | 1063 | 0.020 |
Why?
|
| Hypophysectomy | 1 | 1988 | 113 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1994 | 2726 | 0.020 |
Why?
|
| Histamine Release | 1 | 1988 | 142 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 1988 | 142 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1988 | 547 | 0.020 |
Why?
|
| Cell Membrane | 2 | 1987 | 3748 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1994 | 3128 | 0.020 |
Why?
|
| Trazodone | 1 | 1987 | 66 | 0.020 |
Why?
|
| Pentobarbital | 1 | 1988 | 155 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1994 | 1341 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 1987 | 156 | 0.020 |
Why?
|
| Aggression | 1 | 1992 | 753 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1991 | 1801 | 0.020 |
Why?
|
| Gift Giving | 1 | 2007 | 80 | 0.020 |
Why?
|
| Reproduction | 1 | 1991 | 668 | 0.020 |
Why?
|
| Midazolam | 1 | 1988 | 270 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 1988 | 275 | 0.020 |
Why?
|
| Arousal | 1 | 1992 | 1165 | 0.020 |
Why?
|
| Female | 13 | 2007 | 380194 | 0.020 |
Why?
|
| Body Temperature | 1 | 1989 | 777 | 0.020 |
Why?
|
| Transfection | 1 | 1994 | 5892 | 0.020 |
Why?
|
| Biological Transport | 1 | 1990 | 2118 | 0.020 |
Why?
|
| Norepinephrine | 1 | 1988 | 909 | 0.020 |
Why?
|
| Mice, Inbred ICR | 3 | 1992 | 352 | 0.020 |
Why?
|
| Electroconvulsive Therapy | 1 | 1991 | 477 | 0.020 |
Why?
|
| Morphine | 1 | 1990 | 657 | 0.020 |
Why?
|
| Valproic Acid | 1 | 1988 | 445 | 0.020 |
Why?
|
| Caffeine | 1 | 1989 | 699 | 0.020 |
Why?
|
| Industry | 1 | 2007 | 365 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 6622 | 0.020 |
Why?
|
| Equipment and Supplies | 1 | 2007 | 281 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1988 | 1472 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1986 | 689 | 0.010 |
Why?
|
| Family Practice | 1 | 2007 | 516 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1988 | 2327 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1988 | 934 | 0.010 |
Why?
|
| Posture | 1 | 1988 | 958 | 0.010 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1993 | 1444 | 0.010 |
Why?
|
| Cell Survival | 1 | 1993 | 5882 | 0.010 |
Why?
|
| Serotonin | 1 | 1988 | 1017 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1991 | 1403 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1994 | 2708 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1988 | 1240 | 0.010 |
Why?
|
| Adenine | 1 | 1988 | 936 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1988 | 1124 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1990 | 3913 | 0.010 |
Why?
|
| Trachea | 1 | 1988 | 1076 | 0.010 |
Why?
|
| Gestational Age | 1 | 1991 | 3493 | 0.010 |
Why?
|
| Leukocyte Count | 2 | 1983 | 1588 | 0.010 |
Why?
|
| Synapses | 1 | 1991 | 1728 | 0.010 |
Why?
|
| Diet | 2 | 1990 | 7939 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1987 | 1423 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1991 | 3200 | 0.010 |
Why?
|
| Body Weight | 1 | 1991 | 4669 | 0.010 |
Why?
|
| Adult | 10 | 1990 | 214055 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1988 | 6314 | 0.010 |
Why?
|
| Internal Medicine | 1 | 2007 | 1009 | 0.010 |
Why?
|
| Alcoholism | 1 | 1990 | 1906 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1994 | 7722 | 0.010 |
Why?
|
| United States | 3 | 2007 | 69872 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 1993 | 3265 | 0.010 |
Why?
|
| Software | 1 | 1993 | 4443 | 0.010 |
Why?
|
| Dementia | 1 | 1993 | 2518 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1988 | 6386 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1982 | 530 | 0.010 |
Why?
|
| Flow Cytometry | 3 | 1982 | 5974 | 0.010 |
Why?
|
| Data Collection | 1 | 2007 | 3341 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1989 | 3188 | 0.010 |
Why?
|
| Anxiety | 1 | 1991 | 4297 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1982 | 506 | 0.010 |
Why?
|
| Anesthesiology | 1 | 2007 | 1060 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1990 | 11366 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1987 | 2585 | 0.010 |
Why?
|
| Cardiology | 1 | 2007 | 1668 | 0.010 |
Why?
|
| General Surgery | 1 | 2007 | 1636 | 0.010 |
Why?
|
| Reinforcement Schedule | 1 | 1994 | 129 | 0.010 |
Why?
|
| Cell Line | 1 | 1988 | 15997 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2007 | 12245 | 0.010 |
Why?
|
| Paranoid Disorders | 1 | 1993 | 60 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1982 | 1886 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 13408 | 0.010 |
Why?
|
| Sleep | 1 | 1988 | 4623 | 0.010 |
Why?
|
| Genetics, Behavioral | 1 | 1992 | 53 | 0.010 |
Why?
|
| Pediatrics | 1 | 2007 | 3475 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1992 | 380 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1992 | 156 | 0.010 |
Why?
|
| Middle Aged | 7 | 1990 | 213383 | 0.010 |
Why?
|
| Delusions | 1 | 1993 | 300 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 1983 | 4234 | 0.000 |
Why?
|
| Methacholine Chloride | 1 | 1988 | 233 | 0.000 |
Why?
|
| Potassium Chloride | 1 | 1988 | 237 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1988 | 299 | 0.000 |
Why?
|
| Oligonucleotides | 1 | 1991 | 572 | 0.000 |
Why?
|
| Naltrexone | 1 | 1990 | 307 | 0.000 |
Why?
|
| Exploratory Behavior | 1 | 1988 | 270 | 0.000 |
Why?
|
| Arachidonic Acid | 1 | 1988 | 434 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1988 | 1386 | 0.000 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1991 | 1375 | 0.000 |
Why?
|
| Risk Factors | 1 | 1993 | 72290 | 0.000 |
Why?
|
| Obesity | 1 | 1987 | 12745 | 0.000 |
Why?
|
| Acetylation | 1 | 1987 | 1085 | 0.000 |
Why?
|
| Aged | 6 | 1993 | 163280 | 0.000 |
Why?
|
| Random Allocation | 1 | 1987 | 2429 | 0.000 |
Why?
|
| Drug Therapy, Combination | 1 | 1993 | 6489 | 0.000 |
Why?
|
| Therapeutic Irrigation | 1 | 1982 | 301 | 0.000 |
Why?
|
| Acute Disease | 1 | 1991 | 7149 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1993 | 6442 | 0.000 |
Why?
|
| Outpatients | 1 | 1987 | 1486 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1982 | 13102 | 0.000 |
Why?
|
| Cell Separation | 1 | 1982 | 1751 | 0.000 |
Why?
|
| Patient Compliance | 1 | 1987 | 2684 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1991 | 9146 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1982 | 2617 | 0.000 |
Why?
|
| Phenotype | 1 | 1992 | 16365 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1991 | 18029 | 0.000 |
Why?
|
| Neutrophils | 1 | 1982 | 3719 | 0.000 |
Why?
|
| Lung | 1 | 1988 | 9856 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1982 | 4034 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1982 | 6364 | 0.000 |
Why?
|
| Adolescent | 1 | 1987 | 85781 | 0.000 |
Why?
|
Concepts
(326)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_